Alphamab Oncology 康寧傑瑞生物製藥
Pay for financial year ended 2023-12-31
Source: Annual report
Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.
| Name | Last position |
Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|---|
CNY '000 |
||||||||
Directors |
||||||||
| 1 | Guo, Zijian (1962) 郭子建 | INED | 378 | 378 | ||||
| 2 | Liu, Yang (1972) 劉陽 | ED | 2,559 | 290 | 124 | 2,973 | ||
| 3 | Wei, Kevin Cheng 蔚成 | INED | 340 | 56 | 396 | |||
| 4 | Wu, Dong (1969) 吳冬 | INED | 344 | 56 | 400 | |||
| 5 | Xu, Kevin Zhan 許湛 | NED | ||||||
| 6 | Xu, Ting (1973) 徐霆 | Ch, CEO, Fdr | 6,548 | 214 | 115 | 6,877 | ||
| Total | 1,062 | 9,107 | 504 | 239 | 112 | 11,024 | ||
Main board pay history
Click on the year-end to see the pay details.
CNY'000
| Year-end | Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | 1,128 | 9,193 | 521 | 244 | 84 | 11,170 | Report |
| 2023-12-31 | 1,062 | 9,107 | 504 | 239 | 112 | 11,024 | Report |
| 2022-12-31 | 996 | 8,583 | 929 | 268 | 174 | 10,950 | Report |
| 2021-12-31 | 899 | 7,599 | 1,890 | 196 | 154 | 10,738 | Report |
| 2020-12-31 | 919 | 5,688 | 2,114 | 78 | 0 | 8,799 | Report |
| 2019-12-31 | 50 | 4,535 | 2,562 | 126 | 48,132 | 55,405 | Report |
| Total | 5,054 | 44,705 | 8,520 | 1,151 | 48,656 | 108,086 |
Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!
Copyright & disclaimer, Privacy policy